Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment
Author:
Publisher
Elsevier BV
Subject
Rheumatology
Reference37 articles.
1. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent;Keane;N Engl J Med,2001
2. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy;Wolfe;Arthritis Rheum,2004
3. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management;Gardam;Lancet Infect Dis,2003
4. Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents;Furst;Ann Rheum Dis,2002
5. French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers;Mariette;Ann Rheum Dis,2003
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;Annals of the Rheumatic Diseases;2022-11-03
2. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;RMD Open;2022-11
3. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results;Clinical Rheumatology;2020-10-15
4. Tst, Quantiferon-tb Gold test and t-spot.Tb test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-tnf therapy;Tuberkuloz ve Toraks;2018-06-30
5. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs;Expert Review of Anti-infective Therapy;2018-06-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3